Home
Conditions
Neuroectodermal Tumors, Primitive

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

727 public trials 122 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Not Yet Recruiting

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

NCT06858501

Conditions: Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, High Risk Neuroblastoma, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

NCT07346157

Conditions: Glioma, Medulloblastoma, Medulloblastoma Recurrent, +9 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Not Yet Recruiting

Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors

NCT07589361

Conditions: Atypical Teratoid/Rhabdoid Tumor (AT/RT), Ependymoma, Germinoma, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Pharmacoscopy for Patients With Refractory Primary Brain Tumors

NCT06804655

Conditions: Astrocytoma, Brain (Nervous System) Cancers, Central Nervous System Neoplasms, +23 more
Locations: University Hospital Basel Basel, Basel-Landschaft, Switzerland

Cantonal Hospital St Gallen Sankt Gallen, Canton of St. Gallen, Switzerland

University Hospital Zurich Zurich, Canton of Zurich, Switzerland

View Trial Details

Not Yet Recruiting

Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5

NCT07537400

Conditions: High-risk Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +8 more
Locations: Shaare Zedek Medical Center Jerusalem, Israel

View Trial Details

Not Yet Recruiting

A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma

NCT07527169

Conditions: Cranial Nerve Diseases, Esthesioneuroblastoma, Olfactory, Metastatic Olfactory Neuroblastoma, +12 more
Locations: UT MD Anderson Houston, Texas, United States

View Trial Details

Not Yet Recruiting

my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

NCT07516353

Conditions: ALL, AML, Acute Lymphoblastic Leukemia ,Lymphomas, +32 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma

NCT07518654

Conditions: Hematologic Diseases, Hematopoetic Stem Cell Transplant, Hematopoetic Stem Cell Transplantation, +32 more
Locations: The Hospital for Sick Children Toronto, Ontario, Canada

CHU Sainte-Justine Montreal, Quebec, Canada

View Trial Details

Not Yet Recruiting

B7-H3.CD28Z.CART in Solid Tumors

NCT07358260

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations: Dana Farber Cancer Institite Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

NCT07291102

Conditions: Glioma, Medulloblastoma, Neoplasms, +7 more
Locations: Children's of Alabama Birmingham, Alabama, United States

Nationwide Children's Hospital Columbus, Ohio, United States

View Trial Details

Neuroectodermal Tumors, Primitive

Neuroectodermal Tumors, Primitive trial results

Related conditions